Sort
64,565 grants matching “drug discovery”
The Role of Aberrant Histone Acetylation in the Pathogenesis of Parkinsonâs Disease and Related Synucleinopathies.
$684,173Frank Soldner · Albert Einstein College Of Medicine · R01 · FY2025 · NS
DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS
$684,119Texas Agrilife Research · P01 · FY2001 · AI
Development of neutral sphingomyelinase 2 (nSMase2) inhibitors for the treatment of Alzheimer's disease
$683,930Takashi Tsukamoto · Johns Hopkins University · R01 · FY2024 · AG
Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes
$683,888Timothy E Sweeney · Inflammatix, Inc. · R44 · FY2021 · GM
Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer
$683,864Xiling Shen · Duke University · U01 · FY2019 · CA
High-throughput identification of common CD8+ T cell responses to SIV and M. tuberculosis in rhesus macaques
$683,815David H Oconnor · University Of Wisconsin-Madison · R24 · FY2020 · OD
Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy
$683,754A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2012 · CA
A microED pipeline for the pharmaceutical and biotechnology industry
$683,728Giovanna Scapin · Nanoimaging Services, Inc. · R44 · FY2022 · GM
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$683,673John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA
Accelerated molecular probe pipeline
$683,601Gerard A Cangelosi · University Of Washington · U01 · FY2013 · AI
Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline
$683,558Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2021 · AI
Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline
$683,558Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2022 · AI
Administrative Core
$683,546Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2012 · AI
Conservation and Sustainable Use of Biodiversity in PNG
$683,533University Of Utah · U01 · FY2003 · TW
A novel physiologically realistic microfluidic in-vitro blood-brain barrier model
$683,504Balabhaskar Prabhakarpandian · Cfd Research Corporation · R44 · FY2012 · GM
Profiling Ras Activated Signal Transduction Pathways
$683,492University Of California Irvine · R33 · FY2004 · CA
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$683,484Ticiana Leal · Emory University · UG1 · FY2024 · CA
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$683,484Ticiana Leal · Emory University · UG1 · FY2025 · CA
HTS for copper-activated inhibitors against MRSA
$683,442Frank Wolschendorf · University Of Alabama At Birmingham · R01 · FY2017 · AI
Development of Novel Antiviral Agents VS West Nile Virus
$683,412Washington University · U01 · FY2004 · AI
Nanofiber Scaffolds for Salivary Gland Regeneration
$683,383Melinda Larsen · State University Of New York At Albany · R01 · FY2020 · DE
Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline
$683,345Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2020 · AI
mRNA Splicing Modulation in Familial Dysautonomia
$683,328Susan A Slaugenhaupt · Massachusetts General Hospital · R37 · FY2020 · NS
mRNA Splicing Modulation in Familial Dysautonomia
$683,328Susan A Slaugenhaupt · Massachusetts General Hospital · R37 · FY2022 · NS
Development of FAPI PET as a Non-invasive Biomarker of Liver Fibrogenesis
$683,258Ali Pirasteh · University Of Wisconsin-Madison · R01 · FY2024 · DK